Sutro Biopharma Inc (STRO)

May 12, 2025

Sutro Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025

May 12, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Barclays PLC - Defense World

May 12, 2025

May 10, 2025

Sutro Biopharma Inc Reports Q1 2025 Revenue of $17.4M, Exceeding Estimates; EPS at -$0.91, Missing Projections - GuruFocus

May 10, 2025

May 10, 2025

Sutro Biopharma First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 10, 2025

May 09, 2025

Sutro Biopharma earnings missed by $0.06, revenue topped estimates - Investing.com Canada

May 09, 2025

May 08, 2025

Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts

May 08, 2025

May 08, 2025

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights - The Manila Times

May 08, 2025

May 08, 2025

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights | STRO Stock News - GuruFocus

May 08, 2025

May 08, 2025

Sutro Biopharma, Inc. Advances ADC Pipeline Focus with Promising Preclinical Results and Strategic Reprioritization - Nasdaq

May 08, 2025

May 07, 2025

Financial Metrics Check: Sutro Biopharma Inc (STRO)’s Ratios for Trailing Twelve Months - DWinneX

May 07, 2025

May 06, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Bought by Invesco Ltd. - Defense World

May 06, 2025

May 02, 2025

Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail

May 02, 2025

May 01, 2025

Sutro Biopharma to Participate in Upcoming Investor Conferences - The Manila Times

May 01, 2025

May 01, 2025

Leading ADC Developer Sutro Biopharma to Present at Citizens and BofA Healthcare Conferences in May - Stock Titan

May 01, 2025

May 01, 2025

New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty - Benzinga

May 01, 2025

May 01, 2025

Sutro Biopharma (NASDAQ:STRO) Earns “Neutral” Rating from HC Wainwright - Defense World

May 01, 2025

Apr 30, 2025

Taking the lead: Sutro Biopharma Inc (STRO) - Sete News

Apr 30, 2025

Apr 30, 2025

Brokerages Set Sutro Biopharma, Inc. (NASDAQ:STRO) Price Target at $6.63 - The AM Reporter

Apr 30, 2025

Apr 29, 2025

Sutro Biopharma Inc [STRO] Investment Appeal on the Rise - knoxdaily.com

Apr 29, 2025

Apr 29, 2025

Demystifying Sutro Biopharma: Insights From 4 Analyst Reviews - Nasdaq

Apr 29, 2025

Apr 29, 2025

A stock that deserves closer examination: Sutro Biopharma Inc (STRO) - uspostnews.com

Apr 29, 2025

Apr 28, 2025

Sutro Biopharma to Highlight its Next-Generation Exatecan and Du - GuruFocus

Apr 28, 2025

Apr 28, 2025

Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025 - The Manila Times

Apr 28, 2025

Apr 28, 2025

Sutro Biopharma Announces Poster Presentations on STRO-004 and XpressCF+® Platform at 2025 AACR Annual Meeting - Nasdaq

Apr 28, 2025

Apr 28, 2025

Revolutionary Dual-Payload Cancer Drug Shows Promise: Sutro's Next-Gen ADC Technology Impresses at AACR 2025 - Stock Titan

Apr 28, 2025

Apr 28, 2025

Sutro Biopharma Inc (STRO) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

Apr 28, 2025

Apr 27, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of “Hold” from Analysts - Defense World

Apr 27, 2025

Apr 26, 2025

Russell Investments Group Ltd. Has $183,000 Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 26, 2025

Apr 25, 2025

New fund will pressure flailing biotechs, as investor frustration boils over - Endpoints News

Apr 25, 2025

Apr 23, 2025

LPL Financial LLC Has $667,000 Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 23, 2025

Apr 22, 2025

Sutro Biopharma Inc (STRO) gets rating Downgrade from H.C. Wainwright - knoxdaily.com

Apr 22, 2025

Apr 22, 2025

Anchoring Your Portfolio: Is STRO Stock a Safe Harbor? - investchronicle.com

Apr 22, 2025

Apr 22, 2025

Take off with Sutro Biopharma Inc (STRO): Get ready for trading - Sete News

Apr 22, 2025

Apr 22, 2025

Sutro Biopharma Inc (NASDAQ: STRO) – Analysts’ Revisions Point To Positive Sentiment - Stocksregister

Apr 22, 2025

Apr 22, 2025

Layoff Tracker: Tempest Axes 80% of Workforce - BioSpace

Apr 22, 2025

Apr 18, 2025

Benign Growth For Sutro Biopharma, Inc. (NASDAQ:STRO) Underpins Stock's 36% Plummet - simplywall.st

Apr 18, 2025

Apr 16, 2025

Sutro Biopharma stock hits 52-week low at $0.54 amid market challenges By Investing.com - Investing.com South Africa

Apr 16, 2025

Apr 16, 2025

Sutro Biopharma stock hits 52-week low at $0.54 amid market challenges - Investing.com Canada

Apr 16, 2025

Apr 15, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Holdings Boosted by American Century Companies Inc. - Defense World

Apr 15, 2025

Apr 14, 2025

Sutro Biopharma announces board member departure By Investing.com - Investing.com Canada

Apr 14, 2025

Apr 14, 2025

Sutro Biopharma announces board member departure - Investing.com Australia

Apr 14, 2025

Apr 12, 2025

Sei Investments Co. Takes Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 12, 2025

Apr 07, 2025

Changing FacesPharma and Biotech HiresMarch 2025 - pharmaphorum

Apr 07, 2025

Apr 07, 2025

Prudential Financial Inc. Increases Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 07, 2025

Apr 05, 2025

Thrivent Financial for Lutherans Acquires Shares of 97,096 Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 05, 2025

Apr 03, 2025

Sutro Biopharma stock hits 52-week low at $0.58 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

Sutro Biopharma stock hits 52-week low at $0.58 amid market challenges - Investing.com

Apr 03, 2025

Apr 02, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Rating of “Hold” from Analysts - Defense World

Apr 02, 2025